158 related articles for article (PubMed ID: 31190442)
21. Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.
Xuan L; Wang Y; Huang F; Fan Z; Xu Y; Sun J; Xu N; Deng L; Li X; Liang X; Luo X; Shi P; Liu H; Wang Z; Jiang L; Yu C; Zhou X; Lin R; Chen Y; Tu S; Huang X; Liu Q
Lancet Oncol; 2020 Sep; 21(9):1201-1212. PubMed ID: 32791048
[TBL] [Abstract][Full Text] [Related]
22. Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
Welch JJG; Flamand Y; Stevenson KE; Neuberg DS; Athale UH; Kelly KM; Laverdiere C; Michon B; Place AE; Sallan SE; Silverman LB; Vrooman LM
Pediatr Blood Cancer; 2023 Nov; 70(11):e30560. PubMed ID: 37461125
[TBL] [Abstract][Full Text] [Related]
23. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module.
Varni JW; Seid M; Smith Knight T; Burwinkle T; Brown J; Szer IS
Arthritis Rheum; 2002 Mar; 46(3):714-25. PubMed ID: 11920407
[TBL] [Abstract][Full Text] [Related]
24. Factors influencing agreement between child self-report and parent proxy-reports on the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales.
Cremeens J; Eiser C; Blades M
Health Qual Life Outcomes; 2006 Aug; 4():58. PubMed ID: 16942613
[TBL] [Abstract][Full Text] [Related]
25. Quality of life during active treatment for pediatric acute lymphoblastic leukemia.
Sung L; Yanofsky R; Klaassen RJ; Dix D; Pritchard S; Winick N; Alexander S; Klassen A
Int J Cancer; 2011 Mar; 128(5):1213-20. PubMed ID: 20473921
[TBL] [Abstract][Full Text] [Related]
26. A Single Center Survey of Health-Related Quality of Life among Acute Myeloid Leukemia Survivors in First Complete Remission.
Cheng MJ; Smith BD; Hourigan CS; Gojo I; Pratz KW; Blackford AL; Mehta AK; Smith TJ
J Palliat Med; 2017 Nov; 20(11):1267-1273. PubMed ID: 28537498
[TBL] [Abstract][Full Text] [Related]
27. Measuring health-related quality of life in Hungarian children with heart disease: psychometric properties of the Hungarian version of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales and the Cardiac Module.
Berkes A; Pataki I; Kiss M; Kemény C; Kardos L; Varni JW; Mogyorósy G
Health Qual Life Outcomes; 2010 Jan; 8():14. PubMed ID: 20109201
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial.
El-Jawahri A; LeBlanc TW; Kavanaugh A; Webb JA; Jackson VA; Campbell TC; O'Connor N; Luger SM; Gafford E; Gustin J; Bhatnagar B; Walker AR; Fathi AT; Brunner AM; Hobbs GS; Nicholson S; Davis D; Addis H; Vaughn D; Horick N; Greer JA; Temel JS
JAMA Oncol; 2021 Feb; 7(2):238-245. PubMed ID: 33331857
[TBL] [Abstract][Full Text] [Related]
29. How young can children reliably and validly self-report their health-related quality of life?: an analysis of 8,591 children across age subgroups with the PedsQL 4.0 Generic Core Scales.
Varni JW; Limbers CA; Burwinkle TM
Health Qual Life Outcomes; 2007 Jan; 5():1. PubMed ID: 17201920
[TBL] [Abstract][Full Text] [Related]
30. Measuring health-related quality of life in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory (PedsQL).
Goldstein SL; Graham N; Warady BA; Seikaly M; McDonald R; Burwinkle TM; Limbers CA; Varni JW
Am J Kidney Dis; 2008 Feb; 51(2):285-97. PubMed ID: 18215706
[TBL] [Abstract][Full Text] [Related]
31. Sleep, fatigue, depression, and quality of life in survivors of childhood acute lymphoblastic leukemia.
Gordijn MS; van Litsenburg RR; Gemke RJ; Huisman J; Bierings MB; Hoogerbrugge PM; Kaspers GJ
Pediatr Blood Cancer; 2013 Mar; 60(3):479-85. PubMed ID: 22887764
[TBL] [Abstract][Full Text] [Related]
32. A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group.
Miller TP; Getz KD; Kavcic M; Li Y; Huang YS; Sung L; Alonzo TA; Gerbing R; Daves M; Horton TM; Pulsipher MA; Pollard J; Bagatell R; Seif AE; Fisher BT; Gamis AS; Aplenc R
Leuk Lymphoma; 2016 Jul; 57(7):1567-74. PubMed ID: 26727639
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.
Zheng DJ; Lu X; Schore RJ; Balsamo L; Devidas M; Winick NJ; Raetz EA; Loh ML; Carroll WL; Sung L; Hunger SP; Angiolillo AL; Kadan-Lottick NS
Cancer; 2018 Feb; 124(3):571-579. PubMed ID: 29112230
[TBL] [Abstract][Full Text] [Related]
34. Comparison of child and family reports of health-related quality of life in pediatric acute lymphoblastic leukemia patients after induction therapy.
Nakajima S; Sato I; Soejima T; Koh K; Kato M; Okamoto Y; Imamura T; Maeda M; Ishida Y; Manabe A; Kamibeppu K
BMC Pediatr; 2020 Aug; 20(1):390. PubMed ID: 32814552
[TBL] [Abstract][Full Text] [Related]
35. Symptom Clusters and Influencing Factors in Children With Acute Leukemia During Chemotherapy.
Li R; Ma J; Chan Y; Yang Q; Zhang C
Cancer Nurs; 2020; 43(5):411-418. PubMed ID: 31107701
[TBL] [Abstract][Full Text] [Related]
36. Self-reported quality of life of young children with conditions from early infancy: a systematic review.
Jardine J; Glinianaia SV; McConachie H; Embleton ND; Rankin J
Pediatrics; 2014 Oct; 134(4):e1129-48. PubMed ID: 25246620
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life in Japanese children with acute lymphoblastic leukemia during and after chemotherapy.
Kobayashi K; Nakagami-Yamaguchi E; Hayakawa A; Adachi S; Hara J; Tokimasa S; Ohta H; Hashii Y; Rikiishi T; Sawada M; Kuriyama K; Kohdera U; Kamibeppu K; Kawasaki H; Oda M; Hori H
Pediatr Int; 2017 Feb; 59(2):145-153. PubMed ID: 27422759
[TBL] [Abstract][Full Text] [Related]
38. A phase I clinical trial to study the safety of treatment with tipifarnib combined with bortezomib in patients with advanced stages of myelodysplastic syndrome and oligoblastic acute myeloid leukemia.
Muus P; Langemeijer S; van Bijnen S; Blijlevens N; de Witte T
Leuk Res; 2021 Jun; 105():106573. PubMed ID: 33915463
[TBL] [Abstract][Full Text] [Related]
39. Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial.
DiNardo CD; Schuh AC; Stein EM; Montesinos P; Wei AH; de Botton S; Zeidan AM; Fathi AT; Kantarjian HM; Bennett JM; Frattini MG; Martin-Regueira P; Lersch F; Gong J; Hasan M; Vyas P; Döhner H
Lancet Oncol; 2021 Nov; 22(11):1597-1608. PubMed ID: 34672961
[TBL] [Abstract][Full Text] [Related]
40. Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.
Johnston DL; Alonzo TA; Gerbing RB; Hirsch B; Heerema NA; Ravindranath Y; Woods WG; Lange BJ; Gamis AS; Raimondi SC
Pediatr Blood Cancer; 2013 Dec; 60(12):2073-8. PubMed ID: 24039149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
